Related Experiment Videos
Hidradenitis suppurativa: a review.
1CancerCare Manitoba, Winnipeg, Manitoba, Canada. mwiseman@excite.com
Dermatologic Therapy
|February 6, 2004
Summary
Hidradenitis suppurativa (HS) is a chronic skin disease affecting apocrine glands. Understanding HS pathogenesis and effective treatments, beyond surgery and antimicrobials, is crucial for managing this condition.
Area of Science:
- Dermatology
- Immunology
- Genetics
Background:
- Hidradenitis suppurativa (HS) is a chronic, recurrent inflammatory skin condition.
- It affects apocrine-bearing skin, particularly in intertriginous areas.
- HS has a variable clinical course, ranging from mild nodules to severe scarring and potential malignancy.
Purpose of the Study:
- To review the current understanding of hidradenitis suppurativa pathogenesis.
- To discuss the variable clinical presentations and complications of HS.
- To explore current and potential therapeutic strategies for HS.
Main Methods:
- Literature review of hidradenitis suppurativa.
- Analysis of disease presentation, contributing factors, and treatment outcomes.
- Synthesis of information on pathogenesis and therapeutic modalities.
Main Results:
- HS pathogenesis involves genetic, hormonal, and infectious factors, but remains incompletely understood.
- Disease severity ranges from isolated nodules to significant scarring and functional impairment.
- Current treatments include surgery, antimicrobials, with emerging options like retinoids and immunosuppressants.
Conclusions:
- Further research is needed to fully elucidate HS pathogenesis.
- Effective management requires a comprehensive approach considering various therapeutic options.
- Addressing the unmet needs in HS treatment is essential for improving patient outcomes.